Skip to main content

Jared Gollob

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jared Gollob

Jared Gollob is recorded as Board Member at Kymera Therapeutics, Inc. (KYMR). The proxy statement of Kymera Therapeutics, Inc. reports total compensation of $2,914,330 for Jared Gollob in fiscal 2025, including a base salary of $507,100. Disclosed compensation is on record for 7 fiscal years. Jared Gollob has spoken on 2 earnings calls across 1 company, most recently for Kymera Therapeutics, Inc. on August 5, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kymera Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Kymera Therapeutics, Inc. (KYMR) $507,100 $2,914,330
2024 Kymera Therapeutics, Inc. (KYMR) $490,000 $5,749,693
2023 Kymera Therapeutics, Inc. (KYMR) $480,000 $3,474,154
2022 Kymera Therapeutics, Inc. (KYMR) $460,006 $2,765,015
2021 Kymera Therapeutics, Inc. (KYMR) $432,635 $3,500,801
2020 Kymera Therapeutics, Inc. (KYMR) $383,210 $1,452,716
2019 Kymera Therapeutics, Inc. (KYMR) $344,908 $688,199

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.